HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dollar Shave Club Founder Steps Down As CEO; Beautycounter Under New Direction; Cosmetics Leadership News

Executive Summary

Jason Goldberger takes the helm of Unilever’s Dollar Shave Club, bringing a wealth of digital and retail experience from stints at Target, Amazon and, most recently, Sur La Table. More personal-care industry executive moves.

You may also be interested in...



Dollar Shave Club Focused On Growth Post-Viral Video Sensation

DSC changed the conversation around men's razors with a 2012 viral video smash in which CEO Michael Dubin championed the "f'ing great" quality, but above all the affordability, of the company's blades. The firm's humorous marketing, chock full of irreverent wit, snark and slapstick, has helped win more than 2 million subscribers to date, but DSC's success also signals a changing marketplace in which value increasingly is prioritized over tech enhancements.

How The EU Artificial Intelligence Regulation Will Overlap With Medical Device Regulations

Artificial intelligence is incorporated into medical devices and IVDs with increasing frequency. But it is only now that the EU is working on how that process will be regulated.

Hyloris Pushes Into South America With Maxigesic IV

Hyloris is on a roll with licensing deals for its Maxigesic IV non-opioid pain treatment, with an extension of its existing agreement with Pharma Bavaria to cover South American territories coming hot on the heels of recent developments in the US and Europe.

Topics

UsernamePublicRestriction

Register

RS150908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel